Catheter Precision
VTAK
5 hedge funds and large institutions have $2.19M invested in Catheter Precision in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
17% less funds holding
Funds holding: 6 → 5 (-1)
21% less capital invested
Capital invested by funds: $2.77M → $2.19M (-$580K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$387K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DY
Dowling & Yahnke
San Diego,
California
|
-$41K |
VTAK Hedge Fund Activity: Q1 2020 in Review
5 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2020, worth a combined $2.19M — down 21% from $2.77M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VTAK and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Royce & Associates, adding an estimated $387K. The largest seller was Dowling & Yahnke, cutting an estimated $41K.
- 5 institutional investors held Catheter Precision (VTAK) as of Q1 2020, down from 6 in Q4 2019.
- Funds reported $2.19M of Catheter Precision stock for Q1 2020, down 21% quarter-over-quarter.
- 0 funds opened new Catheter Precision positions in Q1 2020 and 1 closed out, a net change of -1 holder.
- The largest Catheter Precision buyer in Q1 2020 was Royce & Associates, an estimated $387K added.
- The largest Catheter Precision seller in Q1 2020 was Dowling & Yahnke, an estimated $41K sold.
Based on aggregated 13F filings for Q1 2020.